Ask MedTech-IQ? (6)

us unemployed face higher healthcare premiums - Reuters

TopNews United States

us unemployed face higher healthcare premiums Reuters The subsidies began in March as part of the $787 billion economic stimulus and the nine months of benefits for the first group of recipients expired on ... Federal COBRA subsidy expires Stimulus cutoff will increase health costs for jobless Area Lawmakers Push for COBRA Health Coverage  - -

Jack E. Robinson on troop surge, health care, stimulus - NECN

NECN	Jack E. Robinson on troop surge, health care, stimulus NECN There has been talk of a second federal stimulus to promote job growth, but Robinson is opposed to such an idea. "The only thing the stimulus has been ...

Wrong From the Start: Top Ten Outrageous Claims About the Stimulus - RedState (blog)

Media Matters for America

Wrong From the Start: Top Ten Outrageous Claims About the Stimulus RedState (blog) Department of Health and Human Services spokesman (Associated Press, 11/4/09) FACT: This is one of several attempts by the Obama Administration to define a ... Report: Stimulus created or saved 640000 US jobs White House Plays Media Critic, Part II: VP's Economist Attacks Wall Street ...

Direct Flow Medical, Inc.: Series C $40M

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Molecular Detection, Inc.: Series C $3.3M

Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.

ThermalTherapeutic Systems, Inc.: Series A $2.7M

ThermalTherapeutic Systems (Pittsburgh, PA) a development stage device company focused on portable hyperthermic perfusion system for temperature control of the thoracic or peritoneal cavity, closed a $2.7M Serie A financing. Participants include Originate Ventures, Pittsburgh Life Sciences Greenhouse and Innovation Works.

Virdante Pharmaceuticals, Inc.: Series A $30M

Virdante Pharmaceuticals (Cambridge, MA) a development-stage biopharmaceutical company focused on increasing potency of plasma-derived intravenous immune globulin for the treatment of inflammation and autoimmune disease, closed a $30M Series A financing. Participants include Thomas, McNerney & Partners, Osage Partners, Clarus Ventures, Venrock, MedImmune Ventures and Biogen Idec New Ventures.

Quinnova Pharmaceuticals, Inc.: Series B $17.4M

Quinnova Pharmaceuticals (Newtown, PA) a commercial-stage specialty biopharma company focused on dermatological drug reformulations and foam delivery systems, closed a $17.4M Series B financing. Participants include Safeguard Scientifics, Thomas, McNerney & Partners, H.I.G. Ventures.